Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

- Asthma
- Completed

Study Title: Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils

Teva Identifier: C38072-AS-30025 | 2015-000865-29

ClinicalTrials.gov Identifier: NCT02452190

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Reslizumab | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 12 Years and older

Trial Duration: September 28, 2015 - January 31, 2018

Phase: Phase 3

Study Type

Interventional